Organon (OGN) Current Assets (2020 - 2026)

Organon's Current Assets history runs 7 years deep, the most recent figure standing at $4.9 billion for Q1 2026.

• In Q1 2026, Current Assets rose 12.83% year-over-year to $4.9 billion; the TTM figure through Mar 2026 stood at $4.9 billion (up 12.83% YoY), while the FY2025 annual figure was $4.4 billion, changed 0.09% from the prior year.
• Current Assets was $4.9 billion for Q1 2026 at Organon, up from $4.4 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $4.9 billion in Q1 2026 to a low of $3.6 billion in Q3 2022.
• Historically, Current Assets has averaged $4.2 billion across 5 years, with a median of $4.3 billion in 2024.
• Biggest YoY gain for Current Assets was 24.92% in 2022; the steepest drop was 17.02% in 2022.
• A 5-year view of Current Assets shows it stood at $3.9 billion in 2022, then increased by 14.68% to $4.5 billion in 2023, then dropped by 3.55% to $4.3 billion in 2024, then grew by 0.09% to $4.4 billion in 2025, then gained by 13.33% to $4.9 billion in 2026.
• The last three Current Assets figures came in at $4.9 billion (Q1 2026), $4.4 billion (Q4 2025), and $4.7 billion (Q3 2025), per Business Quant data.